ImClone/Bristol Seek Priority Review For Erbitux Head And Neck Cancer Indication
Erbitux sBLA filing for head and neck cancer follows independent confirmatory review of Phase III trial.
Erbitux sBLA filing for head and neck cancer follows independent confirmatory review of Phase III trial.